StockNews.com started coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report published on Tuesday. The firm issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Stock Performance
Shares of BLPH stock opened at $0.04 on Tuesday. The stock has a market cap of $440,388.00, a P/E ratio of -0.04 and a beta of 0.70. Bellerophon Therapeutics has a 1 year low of $0.03 and a 1 year high of $0.08. The stock has a 50 day simple moving average of $0.04 and a 200 day simple moving average of $0.05.
About Bellerophon Therapeutics
See Also
- Five stocks we like better than Bellerophon Therapeutics
- CD Calculator: Certificate of Deposit Calculator
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- Top Biotech Stocks: Exploring Innovation Opportunities
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Why Are Stock Sectors Important to Successful Investing?
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.